Home
About Us
About Us
Our Team
News & Press
Why Ultra-Rare Diseases
Our Model
Therapy Tracker
Contact
Select Page
DNM1L High Throughput Drug Screen
Back to Therapy Pipeline
Submitting Organization:
The DNM1L Foundation
Treatment Modality:
Small Molecule (repurposed)
Development Stage:
Preclinical Phase - Target Validation